Live from WIO 2024: Empowering women and the attitude of gratitude

On this episode, Laura Enyedi, MD, Laura Periman, MD, and Dagny Zhu, MD, are live from Women in Ophthalmology discussing the meeting, their takeaways, empowering women and the practice of gratitude. Intro 0:02 In this episode 1:10 What brings you to Women in Ophthalmology? What excites you about this meeting? 1:30 Periman discusses private practice management. 3:06 Zhu and Periman discuss the obstacles women face as leaders in medicine and managing private practice. 4:10 Enyedi, Periman and Zhu discuss the "why" in medicine. 6:22 Enyedi, Zhu and Periman talk about balance between career and family. 9:20 How did you divide up the chapters in your career? 13:21 Enyedi and Periman talk about setbacks. 14:51 Zhu, Enyedi and Periman discuss the mentorship program offered through WIO. 15:39 Periman discusses the financial help provided by the Mend the Gap scholarship. 19:26 Enyedi discusses the community at the WIO meetings. 21:27 Visit the WIO Mentorship Program to learn more about finding a mentor. 22:10 What is coming up for you in the meeting? 22:20 Zhu talks about presenting Periman's study on ocular effects of different cosmetics and discuss the impact of cosmetics on dry eye disease. 23:26 Enyedi discusses her session on bite-sized gratitude and three good things. 27:45 Three good things. 32:30 Thanks 34:45 Laura Enyedi, MD, is a professor of ophthalmology and pediatrics at Duke Eye Center and medical director of South Durham Ophthalmology in North Carolina. Laura M. Periman, MD, is founder and director of DryEye Services and Clinical Research at Periman Eye Institute in Seattle, WA. She can be reached @Dryeyemaster on Twitter. Dagny Zhu, MD, is a cornea, cataract, and refractive surgeon and medical director and partner at NVISION Eye Centers in Rowland Heights, CA. She can be reached on Twitter @DZEyeMD. We'd love to hear from you! Send your comments/questions to [email protected]. Follow us on Twitter @Healio_OSN. Disclosures: The hosts report no relevant financial disclosures.